Mutations in the polycystins PC1 or PC2 cause autosomal dominant polycystic kidney disease (ADPKD), which is characterized by the formation of fluid-filled renal cysts that disrupt renal architecture and function, ultimately leading to kidney failure in the majority of patients. Although the genetic basis of ADPKD is now well established, the physiological function of polycystins remains obscure and a matter of intense debate. The structural determination of both the homomeric PC2 and heteromeric PC1-PC2 complexes, as well as the electrophysiological characterization of PC2 in the primary cilium of renal epithelial cells, provided new valuable insights into the mechanisms of ADPKD pathogenesis. Current findings indicate that PC2 can function independently of PC1 in the primary cilium of renal collecting duct epithelial cells to form a channel that is mainly permeant to monovalent cations and is activated by both membrane depolarization and an increase in intraciliary calcium. In addition, PC2 functions as a calcium-activated calcium release channel at the endoplasmic reticulum membrane. Structural studies indicate that the heteromeric PC1-PC2 complex comprises one PC1 and three PC2 channel subunits. Surprisingly, several positively-charged residues from PC1 occlude the ionic pore of the PC1-PC2 complex, suggesting that pathogenic polycystin mutations might cause ADPKD independently of an effect on channel permeation. Emerging reports of novel structural and functional findings on polycystins will continue to elucidate the molecular basis of ADPKD. Main text Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common human monogenic diseases, with a prevalence of about 1 in 1000 1,2. This multi-system inherited disorder is characterized by the progressive development of fluid-filled cysts in the kidney, liver and pancreas, and is associated with hypertension, kidney failure and brain aneurysms 3,4. Mutations that cause ADPKD occur on PKD1 and PKD2, which encode polycystin 1 (PC1; also known as PKD1) and polycystin 2 (PC2; also known as PKD2 or TRPP2), respectively 5,6. Mutations in PKHD1, which encodes fibrocystin (also known as polyductin), cause the autosomal recessive form of the disease (ARPKD) 7. One study proposed that the carboxy-terminal domain of fibrocystin binds to the intracellular amino terminus of PC2 and that loss of fibrocystin results in reduced PC2 expression 8 ; however, another study did not confirm this interaction between fibrocystin and PC2 8,9. Additional reported partners for PC2 include other ion channel subunits such as the transient receptor potential (TRP) channels TRPV4 and TRPC1, and the Piezo1 mechanosensitive ion channel 10-15 .